<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Osivax Creates Universal Influenza and Coronavirus Vaccine
Image Overlay - Osivax Creates Universal Influenza and Coronavirus Vaccine

Osivax Creates Universal Influenza and Coronavirus Vaccine

July 16, 2020

Osivax Creates Universal Influenza and Coronavirus Vaccine

French biotech Osivax was granted 30 million euros in public funding for the development of a universal vaccine against both influenza and coronavirus. With 21 GMP certified depots located around the world, including Europe, Yourway provides all customers with quality assurance and is focused on regulatory compliance--this is crucial when testing a vaccine around the world.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat
Come chat with us!
Hello! How can I help you?